Literature DB >> 6491380

Enteric lesions and diarrhea in gnotobiotic calves monoinfected with Cryptosporidium species.

J Heine, J F Pohlenz, H W Moon, G N Woode.   

Abstract

The pathogenicity of Cryptosporidium species was studied by inoculation of two gnotobiotic calves with cryptosporidial oocysts that had been decontaminated by treatment with peracetic acid. Two control calves were inoculated with similar material from which the oocysts had been removed by filtration. Oocyst-inoculated animals shed Cryptosporidium in their feces and developed depression, weakness, anorexia, and diarrhea. At necropsy five days after inoculation, endogeneous stages of Cryptosporidium were found in association with epithelial cells throughout the small and large intestines of these animals. The parasites were most numerous in the lower small intestine. Atrophic villi, disordered and degenerate villous epithelium, and hyperplastic crypt epithelium were associated with infection in the small intestine. Control animals remained normal. Extraneous agents were not detected in any of the calves. The results indicate that Cryptosporidium can destroy intestinal epithelial cells and cause diarrhea in monoinfected gnotobiotic calves.

Entities:  

Mesh:

Year:  1984        PMID: 6491380      PMCID: PMC7109781          DOI: 10.1093/infdis/150.5.768

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Development and validation of a cell culture based assay for in vitro assessment of anticryptosporidial compounds.

Authors:  M Najdrowski; A R Heckeroth; C Wackwitz; S Gawlowska; U Mackenstedt; D Kliemt; A Daugschies
Journal:  Parasitol Res       Date:  2007-01-10       Impact factor: 2.289

2.  Experimental cryptosporidiosis in mice, calves and chicken.

Authors:  S Pohjola; L A Lindberg
Journal:  Acta Vet Scand       Date:  1986       Impact factor: 1.695

3.  Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.

Authors:  R C Langer; M W Riggs
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.

Authors:  Michael W Riggs; Deborah A Schaefer; Sushila J Kapil; Lise Barley-Maloney; Lance E Perryman
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

5.  Infectivity and neutralization of Cryptosporidium parvum sporozoites.

Authors:  M W Riggs; L E Perryman
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.

Authors:  Michael Imboden; Michael W Riggs; Deborah A Schaefer; E Jane Homan; Robert D Bremel
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

7.  Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum.

Authors:  L E Perryman; M W Riggs; P H Mason; R Fayer
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 8.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

9.  Detection of Cryptosporidium parvum oocysts in bovine feces by monoclonal antibody capture enzyme-linked immunosorbent assay.

Authors:  K Z Anusz; P H Mason; M W Riggs; L E Perryman
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

10.  Neutralization-sensitive epitopes are conserved among geographically diverse isolates of Cryptosporidium parvum.

Authors:  E W Uhl; R M O'Connor; L E Perryman; M W Riggs
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.